Superworth

Zimmer Biomet price to free cash flow ZBH

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026
12.3×
10-year median
17.2×
Against its 10-year history
7th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.9× to 39.0×
Peer median
25.1×

Zimmer Biomet's price to free cash flow is 12.3× as of Oct 23, 2026.

That is below its ten-year median of 17.2×, lower than on 93% of days in the last ten years.

Over that time it ranged from 10.9× in May 2026 to 39.0× in May 2021.

The median for 10 medical device stocks of a similar size is 25.1×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far12.3×10.9×13.1×
202512.1×11.8×17.2×
202415.6×15.6×28.5×
202326.9×19.7×26.9×
202220.7×15.5×20.7×
202118.1×17.2×39.0×
202029.2×12.5×29.2×
201922.4×12.8×22.8×
201812.6×12.2×16.7×
201714.4×13.2×18.9×
201616.5×15.7×27.1×
201527.3×20.0×28.5×
201421.3×16.9×21.5×
201317.0×11.0×17.0×
201210.4×9.2×10.8×
20119.1×8.1×12.4×
20108.8×7.8×10.6×

Against its peers

Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.

CompanyPrice to free cash flow
ZBHZimmer Biomet12.3×
DXCMDexCom20.9×
GEHCGE HealthCare Technologies20.4×
EWEdwards Lifesciences35.8×
BSXBoston Scientific18.3×
LIVNLivaNova30.1×
ITGRInteger38.4×
SYKStryker25.1×
MDTMedtronic19.9×
TMDXTransMedics31.0×
ABTAbbott Laboratoriesn/m
Peer median25.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Zimmer Biomet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.